Clinical Trial Update: Open Label, Dose Escalation Study for the Safety and Efficacy of STP705 in Adult Patients With isSCC [Phase 1, Phase 2]

View source ↗

Summary

Open-label dose-escalation study assessing safety and efficacy of STP705 in adults with in situ squamous cell carcinomas related conditions (Bowen's Disease and…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bowen Disease
• Cutaneous Squamous Cell Carcinoma in Situ

Drugs mentioned

• STP705

Snippet

Sponsor: Sirnaomics | Conditions: Bowen's Disease, Cutaneous Squamous Cell Carcinoma in Situ | Phase 1, Phase 2 | Status: COMPLETED